EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Interplay of Splicing and Metabolism in Cancer

Dillon M Voss, Yange Cui iD, Peter S Klein iD

Cells · 20.06.2026 · 15 (12) · 1117

DOI: 10.3390/cells15121117 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 20.06.2026. Verfasst von Dillon M Voss und 2 weiteren Autor:innen. Beteiligte Einrichtung: Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Neoplasms, RNA Splicing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, Leukemia and Lymphoma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant RNA splicing and metabolic reprogramming are defining hallmarks of cancer that were historically studied as parallel processes. Increasing evidence now reveals extensive crosstalk between these pathways, whereby RNA splicing reshapes metabolic circuits, and metabolic states reciprocally influence splice-site selection and spliceosome activity. In this review, we synthesize recent mechanistic insights into how splicing programs regulate metabolic adaptation across diverse cancer contexts. We discuss recurrent oncogenic mutations in spliceosomal components and dysregulation of RNA-binding proteins (RBPs) that drive alternative splicing events in key metabolic regulators, which promote metabolic plasticity required for tumor growth. We further examine how metabolites and nutrient-sensing pathways directly modulate splicing factor activity, spliceosome dynamics, and RNA processing. We also summarize a new mechanism of mitochondrial quality control mediated by retrograde signals from mitochondria to the spliceosome to enhance mitophagy of dysfunctional mitochondria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA SplicingHumansMetabolic ReprogrammingAnimalsMitochondriaSpliceosomesAlternative SplicingRNA-Binding ProteinsMitophagy

Stichwörter der Autor:innen

PINK1cancerleukemiametabolismmitophagymyelodysplasiapyruvate kinaseretrograde signalingspliceosomesplicing

Substanzen

RNA-Binding Proteins

Autor:innen und Institutionen

  • Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
  • Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Yange Cui, Peter S Klein

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • Leukemia and Lymphoma Society
  • American Society of Hematology
  • Penn Institute for RNA Innovation

Zitieren

APA

Voss, D. M., Cui, Y., & Klein, P. S. (2026). The Interplay of Splicing and Metabolism in Cancer. Cells, 15(12), 1117. https://doi.org/10.3390/cells15121117

Vancouver

Voss DM, Cui Y, Klein PS. The Interplay of Splicing and Metabolism in Cancer. Cells. 2026;15(12):1117. doi:10.3390/cells15121117

BibTeX
@article{Voss2026,
  author = {Voss, Dillon M and Cui, Yange and Klein, Peter S},
  title = {The Interplay of Splicing and Metabolism in Cancer},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {1117},
  doi = {10.3390/cells15121117}
}
Kostenlos starten →